Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 52


Inositol-Requiring Enzyme 1-Mediated Downregulation of MicroRNA (miR)-146a and miR-155 in Primary Dermal Fibroblasts across Three TNFRSF1A Mutations Results in Hyperresponsiveness to Lipopolysaccharide.

Harrison SR, Scambler T, Oubussad L, Wong C, Wittmann M, McDermott MF, Savic S.

Front Immunol. 2018 Feb 6;9:173. doi: 10.3389/fimmu.2018.00173. eCollection 2018.


Alternative splicing regulation in tumor necrosis factor-mediated inflammation.

López-Urrutia E, Campos-Parra A, Herrera LA, Pérez-Plasencia C.

Oncol Lett. 2017 Nov;14(5):5114-5120. doi: 10.3892/ol.2017.6905. Epub 2017 Sep 6.


Potential of IL-1, IL-18 and Inflammasome Inhibition for the Treatment of Inflammatory Skin Diseases.

Fenini G, Contassot E, French LE.

Front Pharmacol. 2017 May 22;8:278. doi: 10.3389/fphar.2017.00278. eCollection 2017. Review.


Disease Phenotype and Outcome Depending on the Age at Disease Onset in Patients Carrying the R92Q Low-Penetrance Variant in TNFRSF1A Gene.

Ruiz-Ortiz E, Iglesias E, Soriano A, Buján-Rivas S, Español-Rego M, Castellanos-Moreira R, Tomé A, Yagüe J, Antón J, Hernández-Rodríguez J.

Front Immunol. 2017 Mar 27;8:299. doi: 10.3389/fimmu.2017.00299. eCollection 2017.


Canakinumab reverses overexpression of inflammatory response genes in tumour necrosis factor receptor-associated periodic syndrome.

Torene R, Nirmala N, Obici L, Cattalini M, Tormey V, Caorsi R, Starck-Schwertz S, Letzkus M, Hartmann N, Abrams K, Lachmann H, Gattorno M.

Ann Rheum Dis. 2017 Jan;76(1):303-309. doi: 10.1136/annrheumdis-2016-209335. Epub 2016 Jul 29.


Canakinumab treatment for patients with active recurrent or chronic TNF receptor-associated periodic syndrome (TRAPS): an open-label, phase II study.

Gattorno M, Obici L, Cattalini M, Tormey V, Abrams K, Davis N, Speziale A, Bhansali SG, Martini A, Lachmann HJ.

Ann Rheum Dis. 2017 Jan;76(1):173-178. doi: 10.1136/annrheumdis-2015-209031. Epub 2016 Jun 7.


Genetically defined autoinflammatory diseases.

de Jesus AA, Goldbach-Mansky R.

Oral Dis. 2016 Oct;22(7):591-604. doi: 10.1111/odi.12448. Epub 2016 Apr 14. Review.


Treating rheumatological diseases and co-morbidities with interleukin-1 blocking therapies.

Cavalli G, Dinarello CA.

Rheumatology (Oxford). 2015 Dec;54(12):2134-44. doi: 10.1093/rheumatology/kev269. Epub 2015 Jul 23. Review.


The novel S59P mutation in the TNFRSF1A gene identified in an adult onset TNF receptor associated periodic syndrome (TRAPS) constitutively activates NF-κB pathway.

Greco E, Aita A, Galozzi P, Gava A, Sfriso P, Negm OH, Tighe P, Caso F, Navaglia F, Dazzo E, De Bortoli M, Rampazzo A, Obici L, Donadei S, Merlini G, Plebani M, Todd I, Basso D, Punzi L.

Arthritis Res Ther. 2015 Apr 3;17:93. doi: 10.1186/s13075-015-0604-7.


Interleukin-1 as a common denominator from autoinflammatory to autoimmune disorders: premises, perils, and perspectives.

Lopalco G, Cantarini L, Vitale A, Iannone F, Anelli MG, Andreozzi L, Lapadula G, Galeazzi M, Rigante D.

Mediators Inflamm. 2015;2015:194864. doi: 10.1155/2015/194864. Epub 2015 Feb 16. Review.


Molecular mechanisms in genetically defined autoinflammatory diseases: disorders of amplified danger signaling.

de Jesus AA, Canna SW, Liu Y, Goldbach-Mansky R.

Annu Rev Immunol. 2015;33:823-74. doi: 10.1146/annurev-immunol-032414-112227. Epub 2015 Feb 20. Review.


Untangling the web of systemic autoinflammatory diseases.

Rigante D, Lopalco G, Vitale A, Lucherini OM, Caso F, De Clemente C, Molinaro F, Messina M, Costa L, Atteno M, Laghi-Pasini F, Lapadula G, Galeazzi M, Iannone F, Cantarini L.

Mediators Inflamm. 2014;2014:948154. doi: 10.1155/2014/948154. Epub 2014 Jul 15. Review.


Recurrent fevers in children: TRAPS for young players.

Hodgson KA, Crawford NW, Akikusa JD.

BMJ Case Rep. 2014 Apr 12;2014. pii: bcr2013201627. doi: 10.1136/bcr-2013-201627.


Monogenic autoinflammatory syndromes: state of the art on genetic, clinical, and therapeutic issues.

Caso F, Rigante D, Vitale A, Lucherini OM, Costa L, Atteno M, Compagnone A, Caso P, Frediani B, Galeazzi M, Punzi L, Cantarini L.

Int J Rheumatol. 2013;2013:513782. doi: 10.1155/2013/513782. Epub 2013 Oct 24. Review.


The Central Role of Anti-IL-1 Blockade in the Treatment of Monogenic and Multi-Factorial Autoinflammatory Diseases.

Federici S, Martini A, Gattorno M.

Front Immunol. 2013 Oct 31;4:351. doi: 10.3389/fimmu.2013.00351. Review.


Monogenic autoinflammatory diseases: disorders of amplified danger sensing and cytokine dysregulation.

Sanchez GA, de Jesus AA, Goldbach-Mansky R.

Rheum Dis Clin North Am. 2013 Nov;39(4):701-34. doi: 10.1016/j.rdc.2013.08.001. Epub 2013 Sep 21. Review.


First report of circulating microRNAs in tumour necrosis factor receptor-associated periodic syndrome (TRAPS).

Lucherini OM, Obici L, Ferracin M, Fulci V, McDermott MF, Merlini G, Muscari I, Magnotti F, Dickie LJ, Galeazzi M, Negrini M, Baldari CT, Cimaz R, Cantarini L.

PLoS One. 2013 Sep 16;8(9):e73443. doi: 10.1371/journal.pone.0073443. eCollection 2013.


Biological treatments: new weapons in the management of monogenic autoinflammatory disorders.

Vitale A, Rigante D, Lucherini OM, Caso F, Muscari I, Magnotti F, Brizi MG, Guerrini S, Patti M, Punzi L, Galeazzi M, Cantarini L.

Mediators Inflamm. 2013;2013:939847. doi: 10.1155/2013/939847. Epub 2013 Jul 21. Review.


The phenotype of TNF receptor-associated autoinflammatory syndrome (TRAPS) at presentation: a series of 158 cases from the Eurofever/EUROTRAPS international registry.

Lachmann HJ, Papa R, Gerhold K, Obici L, Touitou I, Cantarini L, Frenkel J, Anton J, Kone-Paut I, Cattalini M, Bader-Meunier B, Insalaco A, Hentgen V, Merino R, Modesto C, Toplak N, Berendes R, Ozen S, Cimaz R, Jansson A, Brogan PA, Hawkins PN, Ruperto N, Martini A, Woo P, Gattorno M; Paediatric Rheumatology International Trials Organisation (PRINTO), the EUROTRAPS and the Eurofever Project.

Ann Rheum Dis. 2014 Dec;73(12):2160-7. doi: 10.1136/annrheumdis-2013-204184. Epub 2013 Aug 21.


Involvement of the same TNFR1 residue in mendelian and multifactorial inflammatory disorders.

Jéru I, Charmion S, Cochet E, Copin B, Duquesnoy P, Garcia MT, Le Borgne G, Cathebras P, Gaillat J, Karabina S, Dodé C, Lohse P, Hentgen V, Amselem S.

PLoS One. 2013 Jul 24;8(7):e69757. doi: 10.1371/journal.pone.0069757. Print 2013.

Supplemental Content

Support Center